发明名称 |
PHARMACEUTICAL COMPOSITION |
摘要 |
<p>There is disclosed a pharmaceutical composition exhibiting H2-antagonistic activities and/or activities against Helicobacter pyroli in a solid unit dosage adapted for oral administration, which contains 50 - 95 percent by weight of a salt formed between ranitidine and a complex of bismuth with a carboxylic acid selected from tartaric acid and citric acid together 2 - 20 percent by weight of an alkaline salt with the proviso that said alkaline salt is an alk. metal carbonate or alk. earth metal carbonate or hydrogen carbonate, or a mixture thereof. Preferably, the composition is in tablet form and comprises ranitidine bismuth citrate and sodium carbonate. The composition shows improved disintegration and/or dissolution.</p> |
申请公布号 |
SK279591(B6) |
申请公布日期 |
1999.01.11 |
申请号 |
SK19940001060 |
申请日期 |
1992.03.05 |
申请人 |
DOUGLAS STEPHEN J.;HEPPENSTALL COLIN R.;SMITH NORMAN R. |
发明人 |
DOUGLAS STEPHEN J.;HEPPENSTALL COLIN R.;SMITH NORMAN R. |
分类号 |
A61K31/341;A61K;A61K9/20;A61K31/29;A61K31/34;A61K31/345;A61K31/445;A61K31/47;A61K33/00;A61K33/24;A61K47/06;A61P1/00;A61P1/04;(IPC1-7):A61K31/29 |
主分类号 |
A61K31/341 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|